Abeona Therapeutics Q2 EPS $(2.08) Up From $(4.00) YoY
Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(2.08) per share. This is a 48 percent increase over losses of $(4.00) per share from the same period last year.
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers
Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale.
This Low-Float Stock Jumps Around 148%; Here’s 64 Biggest Movers From Yesterday
Gainers
United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million.
The Daily Biotech Pulse: Pfizer-BioNTech’s COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio’s AP-013 Trial Under Independent Investigation
Here's a roundup of top developments in the biotech space over the last 24 hours:
Abeona Therapeutics: Q1 Earnings Insights
Abeona Therapeutics (NASDAQ:ABEO) reported its Q1 earnings results on Friday, May 13, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Abeona Therapeutics Announces AAV204, A Novel AAV Capsid, Demonstrated Robust Macular Transduction Following Para-Retinal Administration In Non-Human Primates
Abeona Therapeutics Inc. (NASDAQ:ABEO), a fully-integrated leader in cell and gene therapy, today announced the presentation of new preclinical data on AAV204 at the Association for Research and Vision in Ophthalmology